THE FACT ABOUT MBL77 THAT NO ONE IS SUGGESTING

Not all clients with CLL require therapy. Even with all the latest developments, the iwCLL however recommends watchful observation for people with asymptomatic condition.86 This suggestion relies on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,1